Promising drug trial for pancreatic cancer halted early
Disease control
Terminated
This study tested a drug called niraparib as a first treatment for people with metastatic pancreatic cancer that has certain gene changes (HR-deficient). Only 2 people enrolled before the trial was stopped early. The goal was to see if the drug could shrink tumors, but results ar…
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated May 17, 2026 00:32 UTC